CN1738896A - 用于治疗狼疮性肾炎的组合物和方法 - Google Patents

用于治疗狼疮性肾炎的组合物和方法 Download PDF

Info

Publication number
CN1738896A
CN1738896A CNA2003801090081A CN200380109008A CN1738896A CN 1738896 A CN1738896 A CN 1738896A CN A2003801090081 A CNA2003801090081 A CN A2003801090081A CN 200380109008 A CN200380109008 A CN 200380109008A CN 1738896 A CN1738896 A CN 1738896A
Authority
CN
China
Prior art keywords
leu
ala
gly
ser
bflp1698
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2003801090081A
Other languages
English (en)
Chinese (zh)
Inventor
M·奥托尔
W·M·穆恩茨
N·肖耶
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth LLC
Original Assignee
Wyeth LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth LLC filed Critical Wyeth LLC
Publication of CN1738896A publication Critical patent/CN1738896A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
CNA2003801090081A 2002-11-21 2003-11-21 用于治疗狼疮性肾炎的组合物和方法 Pending CN1738896A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US42806502P 2002-11-21 2002-11-21
US60/428,065 2002-11-21

Publications (1)

Publication Number Publication Date
CN1738896A true CN1738896A (zh) 2006-02-22

Family

ID=32393343

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2003801090081A Pending CN1738896A (zh) 2002-11-21 2003-11-21 用于治疗狼疮性肾炎的组合物和方法

Country Status (9)

Country Link
US (2) US20050119208A1 (enExample)
EP (1) EP1563056A4 (enExample)
JP (1) JP2006516191A (enExample)
CN (1) CN1738896A (enExample)
AU (1) AU2003295784B2 (enExample)
BR (1) BR0316467A (enExample)
CA (1) CA2504561A1 (enExample)
MX (1) MXPA05005284A (enExample)
WO (1) WO2004047740A2 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020226960A1 (en) 2019-05-03 2020-11-12 Dicerna Pharmaceuticals, Inc. Double-stranded nucleic acid inhibitor molecules with shortened sense strands

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020137077A1 (en) * 2000-10-25 2002-09-26 Hopkins Christopher M. Genes regulated in activated T cells
EP1661986A1 (en) * 2000-11-17 2006-05-31 Nuvelo, Inc. Nucleic acids and polypeptides enocoded thereby that are member of the kallikrein gene familyNovel nucleic acids and polypeptides
US6743619B1 (en) * 2001-01-30 2004-06-01 Nuvelo Nucleic acids and polypeptides
CA2445366A1 (en) * 2001-04-27 2002-11-21 Incyte Genomics, Inc. Molecules for disease detection and treatment
CA2500687A1 (en) * 2002-10-02 2004-04-15 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor

Also Published As

Publication number Publication date
AU2003295784B2 (en) 2009-06-11
EP1563056A4 (en) 2005-12-28
BR0316467A (pt) 2005-10-11
EP1563056A2 (en) 2005-08-17
WO2004047740A3 (en) 2005-02-17
JP2006516191A (ja) 2006-06-29
US20050119208A1 (en) 2005-06-02
US7667020B2 (en) 2010-02-23
CA2504561A1 (en) 2004-06-10
WO2004047740A2 (en) 2004-06-10
US20080009008A1 (en) 2008-01-10
MXPA05005284A (es) 2005-07-25
AU2003295784A1 (en) 2004-06-18

Similar Documents

Publication Publication Date Title
CN1167795C (zh) 肽、dna及抗体
CN1310942C (zh) 校正基因
CN1836048A (zh) 可转导的dna结合蛋白
CN1741741A (zh) 用于治疗狼疮肾炎的组合物和方法
CN1491280A (zh) 滑膜细胞蛋白质
CN1680441A (zh) 新型化合物
CN101065501A (zh) 确定基因毒性的方法
CN1800399A (zh) 磷酸二酯酶8a
CN1592793A (zh) 肝细胞癌－相关基因和多肽,以及检测肝细胞癌的方法
CN1684977A (zh) 多肽与编码这些多肽的核酸和它们用于预防、诊断或治疗肝脏失调和上皮癌的用途
CN1241940C (zh) 新型胶原蛋白样蛋白clac、其前体和它们的编码基因
CN1254377A (zh) 哺乳动物chk1效应物细胞周期关卡蛋白激酶材料与方法
CN1711018A (zh) 导入ganp基因的转基因哺乳动物及其应用
CN1232641C (zh) Tnf/ngf受体家族和其它蛋白质的受体的功能的调节剂
CN1633498A (zh) 新型胰岛素/胰岛素样生长因子/松弛素家族多肽及其dna
CN1630664A (zh) 胱冬酶－8结合蛋白及其制备和使用
CN1390256A (zh) 新型蛋白质及其dna
CN1897951A (zh) h－PRUNE的酶抑制剂在过度表达h－PRUNE的肿瘤转移的预防和治疗中的应用
CN1795205A (zh) Spex组合物和使用方法
CN1195374A (zh) 整合素调节/信号传递的细胞质调节剂
CN1359421A (zh) 新型多肽及其dna
CN1684975A (zh) 治疗缺血性心脏病及充血性心衰竭的人类g蛋白偶联受体及其调节物
CN101039956A (zh) 细胞表面糖蛋白
CN1671843A (zh) 参与转录调控的因子
CN1177864C (zh) 在肝癌组织中具有表达差异的新的人蛋白及其编码序列

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Open date: 20060222